Autism Spectrum Disorder Trial, Recruiting NCT06116552 Sponsor: University of Kansas Medical Center Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06116552
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child has a diagnosis of autism, whether given by a community provider or through an educational assessment (based on what a parent reports).
  • The child is between 9 years 0 months and 12 years 11 months old.
  • The child speaks in phrases or sentences using spoken words (based on what a parent reports).

Who may not be able to join:

  • The child speaks more than one language (based on what a parent reports).
  • The child has a known chromosomal condition, such as Fragile X syndrome or Down syndrome (based on what a parent reports).
  • The child has an intellectual impairment or cognitive disability, meaning an IQ score below 70 (based on what a parent reports).
  • The child has cerebral palsy (based on what a parent reports).
  • The child has vision problems that have not been corrected with glasses or other treatment (based on what a parent reports).
  • The child has very limited spoken language or does not use spoken phrases at all (based on what a parent reports or observation by a clinician).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Meghan M Davidson, PhD, CCC-SLP, University of Kansas Department of Speech-Language Hearing: Communications and Disorders

Phone: 785-864-6430

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Kansas Medical Center
Registry
ClinicalTrials.gov
Start date
10 July 2023
Est. completion
1 July 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percent of correct comprehension questions for more social stories at baseline; Percent of correct comprehension questions for less social stories at baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov